Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent

Experimental Eye Research

Volumn 78, Issue 5, 2004, Pages 973-985

  Smith Thomas, L ^a   Moustafa, M ^a   Spada, C S ^b   Shi, L ^b   Dawson, R A ^a   Wagner, M ^a   Balafa, C ^a   Kedzie, K M ^b   Reagan, J W ^c   Krauss, A H P ^b   Woodward, D F ^b   MacNeil, S ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Fibroblasts; FP receptor; Iridial melanocytes; Latanoprost; Melanogenesis; Prostaglandin F2

Indexed keywords

CATECHOL OXIDASE; LATANOPROST; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTANOIC ACID DERIVATIVE; RECEPTOR ANTIBODY;

ADULT; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; EYE COLOR; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IRIS DISEASE; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MESENCHYME CELL; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST;

ADULT; ANTIHYPERTENSIVE AGENTS; CELLS, CULTURED; COCULTURE TECHNIQUES; DINOPROST; EYE COLOR; FIBROBLASTS; HUMANS; INDOLES; MELANOCYTES; MONOPHENOL MONOOXYGENASE; PROSTAGLANDINS F, SYNTHETIC; RECEPTORS, PROSTAGLANDIN; SKIN;

EID: 12144285997     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.12.003     Document Type: Article

References (36)

1. Albert D.M., Green W.R., Grossniklaus H.E., Zimbric M.L. Xalatan pigment study group. Histopathological findings in iris specimens from patients with glaucoma treated with latanoprost. Invest. Ophthalmol. Vis. Sci. 41:2000;S509.
2. Alm A., Camras C.B., Watson P.G. Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States. Surv. Ophthalmol. 41:1997;S105-SS11.
3. Anthony T.L., Pierce K.L., Stamer D.W., Regan J.W. Prostaglandin F2α receptors in the human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 39:1998;315-321.
4. Bee J., Thorogood P.V. The role of tissue interactions in the skeletogenic differentiation of neural crest cells. Dev. Biol. 78:1980;47-62.
5. Bergh K.M., Wentzel P., Stjernschantz J. Latanoprost acid induces production of endogenous PGE2 in cultured iridial melanocytes. J. Ocular Pharmacol. Therapeutics. 18/5:2002;391-400.
6. Bessou S., Surleve-Bazielle J.E., Sorbier E., Taieb A. Ex vivo reconstruction of the epidermis with melanocytes and the influence of UVB. Pigment Cell Res. 8:1995;241-249.
7. Chakrabarty K.H., Dawson R.A., Harris P., Layton C., Babu M., Gould L., Philips J., Leigh I., Green C., Freedlander E., MacNeil S. Development of autologous human dermal-epidermal composites based on sterilised human allodermis for clinical use. Br. J. Dermatol. 141:1997;811-823.
8. Drago F., Marino A., La Manna C. Alpha-methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro. Exp. Eye Res. 68:1999;85-90.
9. Giambernardi T.A., Rodeck U., Klebe R.J. Bovine serum albumin reverses inhibition of RT-PCR by melanin. BioTechniques. 25:1998;564-566.
10. Goodall T., Buffey J.A., Rennie I.G., Benson M., Parsons M.A., Faulkener M.K., MacNeil S. Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells and retinal epithelial cells. Invest. Ophthalmol. Vis. Sci. 35:1994;826-837.
11. Grierson I., Pfeiffer N., Davies H., Sell E., Wingken-Bohres A., Hoechgresand D. Immunohistochemical evaluation of the iris with proliferation markers after treatment with latanoprost. Invest. Ophthalmol. Vis. Sci. 38:1998;S421.
12. Hearing V.J. Enzymatic control of pigmentation in mammals. FASEB. 5:1991;2902-2909.
13. Hedley S.J., Layton C., Heaton M., Chakrabarty K.H., Dawson R.A., Gawkrodger D.J., MacNeil S. Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. Pigment Cell Res. 15:2002;49-56.
14. Hu D.N., McCormick S.A., Ritch R., Pelton-Henrica K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest. Ophthalmol. Vis. Sci. 34:1993;2210-2219.
15. Hu D.N., McCormick S.A., Orlow S.J., Rosemblat S., Lin A.Y., Wo K. Melanogenesis in cultured human uveal melanocytes. Invest. Ophthalmol. Vis. Sci. 36:1995;931-938.
16. 2α and latanoprost-acid on cultured human iridial melanocytes. Exp. Eye Res. 70:2000;113-120.
17. Johnstone M.A. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am. J. Ophthalmol. 124:1997;544-547.
18. Krauss A.-H.P., Shi L., Woodward D.F. Effects of receptor-selective prostaglandin analogues on melanin production and proliferation of S91 melanoma cells. Invest. Ophthalmol. Vis. Sci. 39:1998;S804.
19. Krauss A.H.-P., Sch L., Spada C.S., Reagan J.W., Woodward D.F. Studies in S91 melanoma cells: effects of prostaglandin F2α Invest. Ophthalmol. Vis. Sci. 41:2000;S250.
20. Lake S., Krook K., Ludgren M., Arvidson M., Hu D.N., Stjernschantz J. Effect of latanoprost on the transcription of tyrosinase and TRP1 in cultured human iridial melanocytes. Invest. Ophthalmol. Vis. Sci. 38:2000;S814.
21. Linduuist N.G., Larsson B.S., Stjernschantz J. Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue. Exp. Eye Res. 68:1999;431-436.
22. Loeffler K.U., Sahm M., Spitznas M. Short-term application of latanoprost does not stimulate melanogenesis in bovine ocular melanin-containing cells in vitro. Ophthalmic Res. 33:2001;102-106.
23. Pfeiffer N., Grierson I., Sell E., Davies H., Wingken-Bohres A., Hochgesand D. Morphological evaluation of the iris after treatment with latanoprost. Invest. Ophthalmol. Vis. Sci. 38:1997;S244.
24. Prota G., Vinceensi M.R., Napolitano A., Selsen G., Stjernschantz J. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomologous monkeys. Pigment Cell Res. 13:2000;147-150.
25. Rheinwald J.G., Green H. Serial cultivation of strains of epidermal keratinocytes: the formation of keratinising colonies for single cells. Cell. 6:1975;331-344.
26. Selen G., Stjernschantz J., Resul B. Prostaglandin-induced iridial pigmentation in primates. Surv. Ophthalmol. 41:1997;S125-S128.
27. Sjoquist B., Johansson A., Stjernshantz J. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Arzneimittelforschung. 49:1999;240-249.
28. Smith-Thomas L.C., Davies J.P., Epstein M.L. Gut promotes neurogenic differentiation of periocular mesenchyme, a chondrogenic neural crest derived cell population. Dev. Biol. 115:1986;293-300.
29. Smith-Thomas L.C., Johnson A.R., Fawcett J.W. The effects of embryonic retinal neurons on neural crest cell differentiation into Schwann cells. Development. 119:1990;925-934.
30. Smith-Thomas L.C., Richardson P., Thody A.J., Graham A., Palmer I., Flemming L., Parsons M.A., Rennie I.G., MacNeil S. Human ocular melanocytes and retinal pigment epithelial cells differ in their melanogenic properties in vivo and in vitro. Curr. Eye Res. 15:1996;1079-1091.
31. Smith-Thomas L.C., Moustafa M., Dawson R.A., Wagner M., Balafa C., Haycock J.W., Krauss A.H.-P., Woodward D.F., MacNeil S. Cellular and hormonal regulation of pigmentation in human ocular melanocytes. Pigment Cell Res. 14:2001;298-309.
32. Stjernschantz J., Selen G., Sjoquist B., Resul B., et al. Practical pharmacology of latanoprost, a phenyl substituted PGF2α analogue. Saumuelsson B. Advances in Prostaglandin, Thromboxane and Leukotriene Research. 1995;513-518 Raven Press, New York.
33. Stjernschantz J., Ocklind A., Wentzel P., Lake S., Hu D.N. Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes. Acta Ophthalmol. Scand. 78:2000;618-622.
34. Wilkerson C.L., Syed N.A., Fisher M.R., Robinson N.L., Wallow H.L., Albert D.M. Melanocytes and iris colour. Light microscopic findings. Arch. Ophthalmol. 114:1996;437-442.
35. Wistrand P.J., Stjernshantz J., Olsson K. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye colour. Surv. Ophthalmol. 41:1997;S129-S138.
36. Yoshii T., Tamura K., Taniguchi T., Akiyama K., Ishiyama I. Water-soluble eumelanin as a PCR inhibitor and a simple method for its removal. Nippon Hoigaku Zasshi. 47:1993;323-329.